跳转至内容
Merck
CN

357871

1-甲基-5-巯基-1H-四氮唑

98%

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C2H4N4S
化学文摘社编号:
分子量:
116.14
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
236-132-2
MDL number:
Assay:
98%
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


assay

98%

form

powder

mp

125-128 °C (lit.)

SMILES string

Cn1nnnc1S

InChI

1S/C2H4N4S/c1-6-2(7)3-4-5-6/h1H3,(H,3,5,7)

InChI key

XOHZHMUQBFJTNH-UHFFFAOYSA-N

General description

5-巯基-1-甲基四唑是一种杂环硫醇衍生物。它可与三甲基镓形成二聚体或四聚体复合物。

Application

5-巯基-1-甲基四唑可用作杂环配体,以研究半配位和全配位铅(II)络合物中铅原子上孤对电子的几何形状和立体化学活性。它可用于中孔MSU-2二氧化硅 和SBA-15中孔二氧化硅的亚微米颗粒的化学改性。


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

4.1A - Other explosive hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

法规信息

监管及禁止进口产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



N Kanazumi et al.
Hepato-gastroenterology, 47(36), 1695-1699 (2001-01-10)
In this study, we examined the influence of clinical treatments in the perioperative period upon PIVKA-II (plasma levels of protein induced by vitamin K absence or antagonist-II) in patients with hepatocellular carcinoma and pancreatobiliary diseases. During a perioperative period, plasma
Damián Pérez-Quintanilla et al.
Journal of nanoscience and nanotechnology, 9(8), 4901-4909 (2009-11-26)
Submicron particles of mesoporous MSU-2 silica have been obtained by using Tergitol NP-9 as nonionic surfactant and TEOS as silica precursor. The material has been chemically modified with 5-mercapto-1-methyltetrazole and characterized by powder X-ray diffraction, TEM, SEM, N2 adsorption, FT-IR
K Kawamoto et al.
Japanese journal of pharmacology, 47(2), 169-178 (1988-06-01)
Liver microsomal vitamin K epoxide reductase activity was determined by measuring the formation of menaquinone-4 from the substrate menaquinone-4 2,3-epoxide. The enzyme was active when dithiothreitol (DTT) was used as a reducing agent, and the activity increased gradually with increasing